Severe aortic stenosis is an increasingly prevalent disease that continues to be associated with significant mortality. Transcatheter aortic valve replacements have been used as an alternative to surgical aortic valve replacement in high-risk patients with multiple comorbidities. In this review, we discuss postoperative considerations pertinent to the successful management of these complicated patients in the intensive care unit.
CribierAEltchaninoffHBashA. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008.
2.
IungBVahanianA. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30:962-970.
3.
FaggianoPAntonini-CanterinFBaldessinFLorussoRD’AloiaACasLD. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound. 2006;4:27.
4.
ThouraniVHAilawadiGSzetoWY. Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg. 2011;91:49-55; discussion 55-56.
5.
RaitenJMGutscheJTHorakJAugoustidesJG. Critical care management of patients following transcatheter aortic valve replacement. F1000Res. 2013;2:62.
6.
LeonMBSmithCRMackM. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
7.
IungBCachierABaronG. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?Eur Heart J. 2005;26:2714-2720.
8.
HolmesDRJrMackMJKaulS. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200-1254.
9.
SmithCRLeonMBMackMJ. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
10.
GenereuxPHeadSJWoodDA. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J. 2012;33:2388-2398.
11.
DehedinBGuinotPGIbrahimH. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036-1043.
12.
DurandEBorzBGodinM. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5:461-467.
13.
MotlochLJRottlaenderDRedaS. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45-53.
14.
GenereuxPHeadSJVan MieghemNM. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317-2326.
15.
TomeyMIGidwaniUKSharmaSK. Cardiac critical care after transcatheter aortic valve replacement. Cardiol Clin. 2013;31:607-618, ix.
16.
DrewsTPasicMBuzS. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg. 2011;59:237-242.
LeonMBPiazzaNNikolskyE. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253-269.
19.
MillerDCBlackstoneEHMackMJ. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832-843.e813.
20.
NuisRJVan MieghemNMSchultzCJ. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1637-1643.
21.
TayELGurvitchRWijesingheN. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4:1290-1297.
22.
DumontTMStockwellDWHorganMA. Venous air embolism: an unusual complication of atlantoaxial arthrodesis: case report. Spine. 2010;35:E1238-E1240.
23.
SchofieldPA. The assessment and management of peri-operative pain in older adults. Anaesthesia. 2014;69(suppl 1):54-60.
24.
Amat-SantosIJDumontEVilleneuveJ. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation. Heart. 2012;98:1583-1590.
25.
HuffmyerJTashjianJRaphaelJJaegerJM. Management of the patient for transcatheter aortic valve implantation in the perioperative period. Semin Cardiothorac Vasc Anesth. 2012;16:25-40.
26.
GroenJABanayanDGuptaSXuSBhaleraoS. Treatment of delirium following cardiac surgery. J Cardiac Surg. 2012;27:589-593.
27.
ReadeMCFinferS. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370:444-454.
28.
KazmierskiJKowmanMBanachM. Incidence and predictors of delirium after cardiac surgery: results from The IPDACS Study. J Psychosom Res. 2010;69:179-185.
29.
van den BoogaardMSchoonhovenLEversAWvan der HoevenJGvan AchterbergTPickkersP. Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med. 2012;40:112-118.
30.
ElyEWInouyeSKBernardGR. Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001;286:2703-2710.
31.
SesslerCNGosnellMSGrapMJ. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338-1344.
32.
MaldonadoJRWysongAvan der StarrePJBlockTMillerCReitzBA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50:206-217.
33.
NelsonLELuJGuoTSaperCBFranksNPMazeM. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428-436.
34.
JakobSMRuokonenEGroundsRM. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307:1151-1160.
35.
PrakanrattanaUPrapaitrakoolS. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care. 2007;35:714-719.
36.
HudetzJAPattersonKMIqbalZ. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2009;23:651-657.
37.
McHenryMMRiceJMatlofHJFlammMDJr.Pulmonary hypertension and sudden death in aortic stenosis. Br Heart J. 1979;41:463-467.
38.
Ben-DorIGoldsteinSAPichardAD. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol. 2011;107:1046-1051.
39.
LuconAOgerEBedossaM. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry. Circ Cardiovasc Interv. 2014;7:240-247.
40.
Rodes-CabauJGutierrezMBagurR. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57:1988-1999.
41.
ChorianopoulosEKrumsdorfUGeisN. Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis. Clin Res Cardiol. 2014;103:65-72.
42.
MassonJBKovacJSchulerG. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv. 2009;2:811-820.
43.
KodaliSKWilliamsMRSmithCR. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
44.
MakkarRRFontanaGPJilaihawiH. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704.
45.
Al AliAMAltweggLHorlickEM. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv. 2008;72:573-578.
46.
DworakowskiRWendlerOHallidayB. Device-dependent association between paravalvar aortic regurgitation and outcome after TAVI. Heart. 2014;100:1939-1945.
47.
BagurRRodes-CabauJGurvitchR. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012;5:540-551.
48.
JilaihawiHChinDVasa-NicoteraM. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J. 2009;157:860-866.
49.
FraccaroCNapodanoMTarantiniG. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc Interv. 2009;2:828-833.
50.
TzikasAvan DalenBMVan MieghemNM. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol. 2011;107:285-289.
51.
JilaihawiHChakravartyTWeissREFontanaGPForresterJMakkarRR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012;80:128-138.
52.
Amat-SantosIJRodes-CabauJUrenaM. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178-188.
53.
NishimuraRAOttoCMBonowRO. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2438-2488.
54.
ToggweilerSBooneRHRodes-CabauJ. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol. 2012;59:2068-2074.
55.
SuhWMWitzkeCFPalaciosIF. Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76:616-620.
56.
GianniniCPetronioASDe CarloM. The incremental value of valvuloarterial impedance in evaluating the results of transcatheter aortic valve implantation in symptomatic aortic stenosis. J Am Soc Echocardiogr. 2012;25:444-453.
57.
DewildeWJOirbansTVerheugtFW. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107-1115.
58.
HorlockerTTWedelDJRowlingsonJC. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35:64-101.
59.
BinderRKBarbantiMYeJ. Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. Catheter Cardiovasc Interv. 2014;83:E221-E226.
60.
ToggweilerSGurvitchRLeipsicJ. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113-118.
61.
ZhuFLeeACheeYE. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2012;(10):CD003587.
62.
HigginsTL. Pro: early endotracheal extubation is preferable to late extubation in patients following coronary artery surgery. J Cardiothorac Vasc Anesth. 1992;6:488-493.
63.
DvirDWaksmanRBarbashIM. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol. 2014;63:269-279.
64.
ZahnRGerckensUGrubeE. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
65.
UssiaGPScarabelliMMuleM. Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis. Catheter Cardiovasc Interv. 2010;76:757-766.
66.
ElhmidiYBleizifferSDeutschMA. Acute kidney injury after transcatheter aortic valve implantation: incidence, predictors and impact on mortality. Arch Cardiovasc Dis. 2014;107:133-139.
67.
StrauchJTSchernerMPHaldenwangPL. Minimally invasive transapical aortic valve implantation and the risk of acute kidney injury. Ann Thorac Surg. 2010;89:465-470.
68.
ElhmidiYBleizifferSPiazzaN. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J. 2011;161:735-739.
69.
BagurRWebbJGNietlispachF. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-874.
70.
AuTHBrucknerAMohiuddinSMHillemanDE. The prevention of contrast-induced nephropathy. Ann Pharmacother. 2014;38:1332-1342.
71.
SaiaFCiucaCTaglieriN. Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. Int J Cardiol. 2013;168:1034-1040.
72.
WenaweserPPilgrimTRothN. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161:1114-1124.
73.
KahlertPAl-RashidFWeberM. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz. 2009;34:398-408.
74.
LardizabalJAO’NeillBPDesaiHV. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. J Am Coll Cardiol. 2013;61:2341-2345.
75.
ThouraniVHKeelingWBKilgoPD. The impact of body mass index on morbidity and short- and long-term mortality in cardiac valvular surgery. J Thorac Cardiovasc Surg. 2011;142:1052-1061.
76.
GreenPWoglomAEGenereuxP. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 2012;5:974-981.
77.
HargravesJD. Glycemic control in cardiac surgery: implementing an evidence-based insulin infusion protocol. Am J Crit Care. 2014;23:250-258.
78.
LazarHLMcDonnellMChipkinSR. The Society of Thoracic Surgeons practice guideline series: glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663-669.
79.
DesaiSVMcClaveSARiceTW. Nutrition in the ICU: an evidence-based approach. Chest. 2014;145:1148-1157.
80.
CasaerMPVan den BergheG. Nutrition in the acute phase of critical illness. N Engl J Med. 2014;370:1227-1236.
81.
PurserJLKuchibhatlaMNFillenbaumGGHardingTPetersonEDAlexanderKP. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc. 2006;54:1674-1681.
82.
MakaryMASegevDLPronovostPJ. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901-908.
